Who Supplies Metformin to India from SOUTH AFRICA

Importing finished pharmaceutical formulations containing Metformin into India requires compliance with the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The Central Drugs Standard Control Organization (CDSCO) mandates that both the drug and the manufacturing site be registered. For new drugs, approval under Rule 122E is necessary before importation. Applications for registration and import licenses must be submitted to the Drugs Controller General of India (DCGI) at CDSCO. The registration process involves submitting Form 40 or 41, along with the required documentation, and may take several months, depending on the completeness of the application and the nature of the drug. Specific requirements for Metformin formulations under HS Code 30049099 include detailed product information, manufacturing details, and evidence of compliance with Indian standards.

Imported Metformin formulations must undergo quality testing at CDSCO-approved laboratories. Batch-wise testing is mandatory, with each batch requiring a Certificate of Analysis (CoA) confirming compliance with Indian Pharmacopoeia standards. Stability data, adhering to ICH Zone IV guidelines, must be provided to demonstrate the product's shelf-life under Indian climatic conditions. Upon arrival, customs drug inspectors conduct port inspections to verify the authenticity and quality of the products. If a batch fails to meet the required standards, it may be rejected, destroyed, or re-exported, depending on the severity of the non-compliance.

Between 2024 and 2026, the CDSCO has implemented stricter regulations for imported medicines to prevent the sale of unapproved or illegal drugs in the Indian market. Import registration and licensing have become mandatory, with the requirement for both import registration and a license from CDSCO as per the Drugs and Cosmetics Act and Rules. Additionally, the Directorate General of Foreign Trade (DGFT) revised Standard Input Output Norms (SION) A-290 in December 2025, changing the Unit of Measurement (UOM) for Metformin HCL inputs from a ratio-based measure to an absolute quantity per unit of export product, effective immediately.

India imports finished Metformin formulations to meet the growing demand for diabetes management, particularly for patented or branded formulations and specific dosage forms not produced domestically. The domestic capacity may not fully satisfy the diverse needs of the Indian market, leading to reliance on imports. The market size for Metformin formulations in India is substantial, with a significant portion of the population requiring these medications for effective diabetes control.

The import duty structure for Metformin formulations under HS Code 30049099 includes a Basic Customs Duty (BCD) of 10%, an Education Cess of 2%, a Secondary Higher Education Cess of 1%, and a Countervailing Duty (CVD) of 6%, totaling 17.10%. There are no additional duties such as the National Calamity Contingent Duty (NCCD) or Anti-Dumping Duty applicable to this product. The Social Welfare Surcharge (SWS) is 10%, and the Integrated Goods and Services Tax (IGST) is applicable as per the prevailing GST rates. Exemptions or concessional rates are not available for imports from South Africa.

India sources Metformin formulations from South Africa due to the availability of patented formulations, specialized dosage forms, and high-quality products that may not be produced domestically. South African manufacturers offer competitive advantages in terms of product innovation and compliance with international quality standards. Other suppliers include China, Germany, and the United States; however, South Africa's share in the Indian market is notable due to these factors.

India imports Metformin formulations from South Africa due to the availability of patented formulations, specialized dosage forms, and high-quality products that may not be produced domestically. South African manufacturers offer competitive advantages in terms of product innovation and compliance with international quality standards.

Compared to other origins such as China, the European Union, and the United States, South Africa offers competitive pricing, high-quality products, and adherence to international regulatory standards. While other countries may offer lower prices, South Africa's unique advantage lies in its product quality and compliance with international standards, making it a preferred source for certain formulations.

Indian importers face risks such as single-source dependency, currency fluctuations, regulatory changes, quality incidents, and shipping disruptions. Past shortages have occurred due to manufacturing issues or regulatory non-compliance. To mitigate these risks, importers should diversify their supplier base, monitor currency trends, stay updated on regulatory changes, and establish contingency plans for supply chain disruptions.

1. 1Dual-Sourcing: Engage multiple suppliers to reduce dependency on a single source.
2. 2Inventory Planning: Maintain adequate stock levels to buffer against supply chain disruptions.
3. 3Payment Terms: Negotiate favorable terms such as Letters of Credit (LC), Documents Against Acceptance (DA), or Documents Against Payment (DP) to manage financial risk.
4. 4Minimum Order Quantities (MOQs): Align order quantities with demand forecasts to optimize inventory costs.
5. 5Supplier Qualification: Conduct thorough due diligence on suppliers, including audits and quality assessments, to ensure compliance with regulatory standards.

1. 1DGFT Importer Exporter Code (IEC): Obtain an IEC from the Directorate General of Foreign Trade.
2. 2CDSCO Registration: Register the product with CDS